A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

February 28, 2029

Conditions
Neuromyelitis Optica Spectrum Disorders
Interventions
DRUG

B001

The subjects will receive IV dose of B001 on Day 1 and Day 15 of RCP

OTHER

Placebo

The subjects will receive IV dose of placebo matched to B001 on Day 1 and Day 15 of the RCP

Trial Locations (51)

Unknown

RECRUITING

Beijing Anzhen Hospital,Capital Medical University, Beijing

RECRUITING

Beijing Tiantan Hospital,Capital Medical University, Beijing

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

RECRUITING

Peking University First Hospital, Beijing

RECRUITING

The First Medical Center of PLA General Hospital, Beijing

RECRUITING

The Third Medical Center of PLA General Hospital, Beijing

RECRUITING

Cangzhou Central Hospital, Cangzhou

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

RECRUITING

Xiangya Hospital Central South University, Changsha

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

RECRUITING

Guangzhou First People's Hospital, Guangzhou

RECRUITING

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

The Affiliated Hospital of Guizhou Medical University, Guiyang

RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

RECRUITING

The Fourth Affiliated Hospital of Harbin Medical University, Harbin

RECRUITING

The Second Affiliated Hospital of Harbin Medical University, Harbin

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

The Second Affiliated Hospital of Anhui Medical University, Hefei

RECRUITING

Huizhou First Hospital, Huizhou

RECRUITING

The First Affiliated Hospital of Shandong First Medical University, Jinan

RECRUITING

Affiliated Hospital of Jining Medical University, Jining

RECRUITING

First Affiliated Hospital of Kunming Medical University, Kunming

RECRUITING

First People's Hospital of Yunnan Province, Kunming

RECRUITING

Jiangxi Provincial People's Hospital, Nanchang

RECRUITING

Nanyang Central Hospital, Nanyang

RECRUITING

Qilu Hospital of Shandong University (Qingdao), Qingdao

RECRUITING

The First Hospital of China Medical University, Shenyang

RECRUITING

Shenzhen Hospital of University of Hong Kong, Shenzhen

RECRUITING

The Second Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

Taihe Hospital, Shiyan

RECRUITING

First Hospital of Shanxi Medical University, Taiyuan

RECRUITING

Shanxi Provincial People's Hospital, Taiyuan

RECRUITING

Tianjin Medical University General Hospital, Tianjin

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

RECRUITING

Tongji Hospital, Wuhan

RECRUITING

The Second Affiliated Hospital of the Chinese People's Liberation Army Air Force Medical University, Xi'an

RECRUITING

Xi'an International Medical Center Hospital, Xi'an

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

RECRUITING

Zhongshan Hospital Xiamen University, Xiamen

RECRUITING

Yan'an University Xianyang Hospital, Xianyang

RECRUITING

Yantai Mountain Hospital in Yantai City, Yantai

RECRUITING

The Central Hospital of Yongzhou, Yongzhou

RECRUITING

Zaozhuang Municipal Hospital, Zaozhuang

RECRUITING

Henan Provincial People's Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Zigong First People's Hospital, Zigong

All Listed Sponsors
collaborator

Shanghai Pharmaceuticals Holding Co., Ltd

INDUSTRY

lead

Shanghai Jiaolian Drug Research and Development Co., Ltd

INDUSTRY